Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Bind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study to Assess Efficacy and Safety of Rimonabant 20 mg Versus Placebo on Weight Loss and Frequency of Binge Episodes in Obese Patients With Food Craving

NCT00481975 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00481975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00481975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Bind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study to Assess Efficacy and Safety of Rimonabant 20 mg Versus Placebo on Weight Loss and Frequency of Binge Episodes in Obese Patients With Food Craving
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2004
Completion date
August 31, 2005
Enrollment
289 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

eating disorders, obesity